The End of Alzheimer’s Program – Dale E. Bredesen, M.D. References
Following is a list of references from the book, The End of Alzheimer’s Program, published by Avery/Random House. Due to the length of the text, these references could not be included in the print version, and therefore are listed below.
3 – Sean Clouston et al., Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring 4, 67–75, 2016
Cognitive Impairment Among World Trade Center Responders: Long-Term Implications of Re-Experiencing the 9/11 Terrorist Attacks
4 – Christa Maynard et al., International Journal of Experimental Pathology 86, no. 3, 147–59, July 2005
Metals and Amyloid in Alzheimer’s Disease
1 – Bryan D. James et al., Neurology 82, no. 12, 1045–50, March 2014
Contribution of Alzheimer Disease to Mortality in the United States
2 – Dale E. Bredesen, Aging 6, no. 9, 707–17, September 2014
Reversal of Cognitive Decline: A Novel Therapeutic Program
2 – Dale E. Bredesen et al., Aging 8, no. 6, 1250–58, June 2016
Reversal of Cognitive Decline in Alzheimer’s Disease
2 – Dale E. Bredesen et al., Journal of Alzheimer Disease & Parkinsonism 8, no. 5, 450, October 2018
Reversal of Cognitive Decline: 100 Patients
3 – Stephanie J. Soscia et al., PloS One 5, no. 3, e9505, March 2010
The Alzheimer’s Disease-Associated Amyloid Beta-Protein is an Antimicrobial Peptide
4 – Bredesen et al.,
Reversal of Cognitive Decline
5 – Christian K. Roberts, Andrea L. Hevener, and R. James Barnard, Comprehensive Physiology 3, no. 1, 1–58, May 2013
Metabolic Syndrome and Insulin Resistance: Underlying Causes and Modification by Exercise Training
1 – Dimitrios Kapogiannis et al., The FASEB Journal 29, no. 2, 589–96, February 2015